Phaarmasia Ltd Share Price

45.8
(-0.41%)
Dec 9, 2024|02:39:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open43.58
  • Day's High45.8
  • 52 Wk High64.75
  • Prev. Close45.99
  • Day's Low43.58
  • 52 Wk Low 24.5
  • Turnover (lac)0.02
  • P/E0
  • Face Value10
  • Book Value8.33
  • EPS0
  • Mkt. Cap (Cr.)31.28
  • Div. Yield0
View All Historical Data
No Records Found

Phaarmasia Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

43.58

Prev. Close

45.99

Turnover(Lac.)

0.02

Day's High

45.8

Day's Low

43.58

52 Week's High

64.75

52 Week's Low

24.5

Book Value

8.33

Face Value

10

Mkt Cap (₹ Cr.)

31.28

P/E

0

EPS

0

Divi. Yield

0

Phaarmasia Ltd Corporate Action

30 Aug 2024

12:00 AM

AGM

Announcement Date: 30 Aug, 2024

arrow

31 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Phaarmasia Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Phaarmasia Ltd SHAREHOLDING SNAPSHOT

09 Dec, 2024|03:03 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 73.51%

Foreign: 0.00%

Indian: 73.51%

Non-Promoter- 0.05%

Institutions: 0.05%

Non-Institutions: 26.42%

Custodian: 0.00%

Share Price

Phaarmasia Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

6.83

6.83

6.83

6.83

Preference Capital

0

0

0

0

Reserves

3.47

3.98

5.23

6.83

Net Worth

10.3

10.81

12.06

13.66

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

19.89

24.45

20.17

14.35

yoy growth (%)

-18.64

21.18

40.52

-33.54

Raw materials

-14.57

-17.79

-10.85

-6.73

As % of sales

73.27

72.76

53.78

46.88

Employee costs

-1.49

-1.58

-1.81

-1.54

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.47

0.96

0.67

0.26

Depreciation

-0.34

-0.39

-0.46

-0.44

Tax paid

-0.16

-0.42

-0.1

-0.1

Working capital

0.19

2.02

0.06

0.41

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-18.64

21.18

40.52

-33.54

Op profit growth

-107.56

24.37

397.72

-39.1

EBIT growth

-50.83

38.23

162.62

7.53

Net profit growth

-42.2

-5.76

252.55

289.14

View Ratios

No Record Found

Phaarmasia Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,804.8

157.084,33,031.98863.290.755,123.6798.33

Divis Laboratories Ltd

DIVISLAB

6,130.1

88.591,62,734.895180.492,302513.62

Cipla Ltd

CIPLA

1,477.6

28.191,19,332.821,178.160.883,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,332.25

68.931,12,773.424600.842,376222.38

Dr Reddys Laboratories Ltd

DRREDDY

1,253.65

21.751,04,602.641,882.10.646,678.8322.48

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Phaarmasia Ltd

Management

Register Office

Registrar Office

Non Executive Director

Vinay Ramakant Sapte

Non Executive Director

Maneesh R Sapte

Whole-time Director

Y N Bhaskara Rao

Non Executive Director

Rashmi V Sapte

Independent Director

PRAVIN M. HEGDE

Independent Director

Ajit G Jamkhandikar

Company Sec. & Compli. Officer

Urvashi Bhatia

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMPcertified and ISO 9001-certified manufacturing facility.
Read More

Company FAQs

What is the Phaarmasia Ltd share price today?

The Phaarmasia Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹45.8 today.

What is the Market Cap of Phaarmasia Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Phaarmasia Ltd is ₹31.28 Cr. as of 09 Dec ‘24

What is the PE and PB ratio of Phaarmasia Ltd?

The PE and PB ratios of Phaarmasia Ltd is 0 and 5.51 as of 09 Dec ‘24

What is the 52 Week High and Low of Phaarmasia Ltd?

The 52-week high/low is the highest and lowest price at which a Phaarmasia Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Phaarmasia Ltd is ₹24.5 and ₹64.75 as of 09 Dec ‘24

What is the CAGR of Phaarmasia Ltd?

Phaarmasia Ltd's CAGR for 5 Years at 18.12%, 3 Years at 17.29%, 1 Year at 72.89%, 6 Month at 32.54%, 3 Month at -11.73% and 1 Month at -12.40%.

What is the shareholding pattern of Phaarmasia Ltd?

The shareholding pattern of Phaarmasia Ltd is as follows:
Promoters - 73.51 %
Institutions - 0.06 %
Public - 26.43 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp